Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany.

Conclusions: This analysis underlines an association between the initiation of rebate contracts and a negative impact on the compliance of breast cancer patients on an adjuvant hormonal treatment The impact of rebate contracts on the health of patients and the health care costs should be evaluated in further therapeutic fields through additional research projects. PMID: 24120719 [PubMed - as supplied by publisher]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Int J Clin Pharmacol Ther Source Type: research